Auristone bags $5.4m in Elev8.vc-led funding round

The startup will use the capital to promote its flagship product.

Auristone has secured $5.4m (US$4m) capital from its latest seed funding round led by venture capital firm Elev8.vc.

SEEDS Capital and existing investor Genedant joined the funding round.

The biotech startup focuses on promoting epigenomics in healthcare through its flagship molecular profiling test, “EPI-CALL,” which assists doctors and late-stage cancer patients navigate different therapy options.

The startup will use the raised funds to expand its clinical collaborations and promote EPI-CALL in the market by working with regional genomic companies.

Follow the link for more news on

startups

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.

If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia